Literature DB >> 13209379

Hexamethonium contributing to fatal shock in hypertensive epistaxis.

A K HRENOFF.   

Abstract

Entities:  

Keywords:  EPISTAXIS/etiology and pathogenesis; HYPERTENSION/therapy; MUSCLE RELAXANTS/injurious effects

Mesh：

Substances：

Year:  1954        PMID： 13209379      PMCID： PMC1532359     

Source DB:  PubMed          Journal:  Calif Med        ISSN： 0008-1264


× No keyword cloud information.
  4 in total

1.  Clinical use of hydralazine and hexamethonium in treatment of hypertension.

Authors:  R R HILKER; P S RHOADS; C E BILLINGS
Journal:  J Am Med Assoc       Date:  1953-09-05

2.  New drug therapies in arterial hypertension.

Authors:  R W WILKINS
Journal:  Ann Intern Med       Date:  1952-12       Impact factor: 25.391

3.  Caution with regard to use of hexamethonium and "apresoline".

Authors:  K S GRIMSON; E S ORGAIN; C R ROWE; H A SIEBER
Journal:  J Am Med Assoc       Date:  1952-05-17

4.  Use of hexamethonium in arterial hypertension.

Authors:  D A RYTAND
Journal:  Calif Med       Date:  1954-05
  4 in total
  1 in total

1.  Fatal epistaxis.

Authors:  F B QUINN
Journal:  Calif Med       Date:  1961-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.